Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial

2002152 citationsJournal Article

Authors

Based on these findings and prior studies, rabeprazole reliably relieves GI symptoms equally well in both nonerosive GERD and erosive GERD.

Good health and well-being

Published in: The American Journal of Gastroenterology

Volume 97, Issue 6, pp. 1332-1339

Field-Weighted Citation Impact: 6.30